Dr. Reddy’s launches generic of Sensipar tablets in U.S.

Dr. Reddy’s Laboratories has launched Cinacalcet Tablets, a therapeutic equivalent generic version of Sensipar (cinacalcet) Tablets in the U.S. market. Sensipar is a trademark of Amgen Inc. The drug is indicated for Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis. The Sensipar brand and generic market …

Read moreDr. Reddy’s launches generic of Sensipar tablets in U.S.